adalimumab
0 sources
adalimumab
Summary
adalimumab is a type of chemical entity[1]. adalimumab ranks in the top 3% of type_of_chemical_entity entities by monthly Wikipedia readership (411 views/month).[2]
Key Facts
- adalimumab's instance of is recorded as type of chemical entity[3].
- adalimumab's chemical structure is recorded as Adalimumab structure.svg[4].
- adalimumab's CAS Registry Number is recorded as 331731-18-1[5].
- adalimumab's EC number is recorded as 695-701-7[6].
- adalimumab's ATC code is recorded as L04AB04[7].
- adalimumab's subclass of is recorded as chemical compound[8].
- adalimumab's has use is recorded as medication[9].
- adalimumab's Commons category is recorded as Adalimumab[10].
- adalimumab's MeSH descriptor ID is recorded as D000068879[11].
- adalimumab's ChEMBL ID is recorded as CHEMBL1201580[12].
- adalimumab's Guide to Pharmacology Ligand ID is recorded as 4860[13].
- adalimumab's Freebase ID is recorded as /m/05_9rs[14].
- adalimumab's UNII is recorded as FYS6T7F842[15].
- adalimumab's KEGG ID is recorded as D02597[16].
- adalimumab's MeSH tree code is recorded as D12.776.124.486.485.114.224.060.250[17].
- adalimumab's MeSH tree code is recorded as D12.776.124.790.651.114.224.060.250[18].
- adalimumab's MeSH tree code is recorded as D12.776.377.715.548.114.224.200.250[19].
- adalimumab's DrugBank ID is recorded as DB00051[20].
- adalimumab's has characteristic is recorded as biopharmaceutical[21].
- adalimumab's HSDB ID is recorded as 7851[22].
- adalimumab's NDF-RT ID is recorded as N0000148789[23].
- adalimumab's medical condition treated is recorded as rheumatoid arthritis[24].
- adalimumab's medical condition treated is recorded as polyarthritis[25].
- adalimumab's medical condition treated is recorded as pyoderma gangrenosum[26].
- adalimumab's medical condition treated is recorded as osteoarthritis susceptibility 1[27].
Why It Matters
adalimumab ranks in the top 3% of type_of_chemical_entity entities by monthly Wikipedia readership (411 views/month).[2] adalimumab has Wikipedia articles in 22 language editions, a strong signal of global cultural recognition.[28] adalimumab is known by 14 alternative names across languages and contexts.[29]